With the mission of “promoting professional promotion and serving public health”, the company is committed to professional academic promotion; meets the unmet therapeutic needs of patients, and focuses on serving patients' health.
With the mission of "being a health promoter and serving the public", the company is committed to professional academic promotion, patient needs and health service.
With the mission of “promoting professional promotion and serving public health”, the company is committed to professional academic promotion; meets the unmet therapeutic needs of patients, and focuses on serving patients' health.
Chongqing Jingdong Junzhuo Pharmaceutical Co., Ltd. attaches great importance to the international market. We pay attention to the international development and effects of new drugs, build a channel for product communication.
With the mission of “promoting professional promotion and serving public health”, the company is committed to professional academic promotion; meets the unmet therapeutic needs of patients, and focuses on serving patients' health.
Follow no set form, be enthusiastic and active, diligent and eager to learn, possessing both political integrity and ability. Talents are symbols of company value, shareholders are creators of value and one of the key elements of company competitiveness and the first factor to achieve the scientific development of the company.
| 【Ingredients】 |
|
|---|---|
| 【Character】 |
This product is a yellow clear liquid. |
| 【Indication】 |
In order to reduce the occurrence of drug-resistant bacteria and maintain the effectiveness of moxifloxacin hydrochloride and other antibacterial drugs, moxifloxacin hydrochloride should be used only for the treatment or prevention of infections that have been proven or strongly suspected to be caused by sensitive bacteria.
The epidemiological and sensitive profiles of local pathogens may contribute to the empirical selection of therapeutic agents in the context of culture and susceptibility information. Appropriate culture and susceptibility testing should be performed prior to treatment to isolate and identify the microorganism causing the infection and determine its sensitivity to moxifloxacin hydrochloride. Moxifloxacin hydrochloride may have been selected for treatment prior to obtaining culture results, and once the culture results are obtained, appropriate treatment should be selected. |
| 【Specifications】 |
20ml: 0.4g / support (based on moxifloxacin) |
| 【usage and dosage】 |
Moxifloxacin hydrochloride tablets and injections are used to treat the following infections caused by sensitive bacteria (≥18 years old) in adults: 1.Acute bacterial sinusitis: caused by Streptococcus pneumoniae, Haemophilus influenzae or Moraxella catarrhalis. 2.acute exacerbation of chronic bronchitis: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, methicillin-sensitive Staphylococcus aureus or Moraxella catarrhalis. 3. Community-acquired pneumonia: from Streptococcus pneumoniae (including multidrug-resistant strains), Haemophilus influenzae, Moraxella catarrhalis, methicillin-sensitive Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae or Caused by Chlamydia pneumoniae. 4. Non-complex skin and skin soft tissue infections: caused by methicillin-sensitive Staphylococcus aureus or Streptococcus pyogenes. 5. Complex skin and skin tissue infections: caused by methicillin-sensitive Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae or Enterobacter cloacae. 6. Complex intra-abdominal infection: from Escherichia coli, Bacteroides fragilis, Streptococcus angina, Streptococcus faecalis, Enterococcus faecalis, Proteus, Clostridium perfringens, Polymorphs or Peptostase Caused, including abdominal abscess. Please refer to the manual for details. |
- Scan code pays attention to us -
National customer service：400 969 7233
Company address：F13, Building A, Shenzhou Zhihui Tiandi, 26 Honghu West Road, Yubei District, Chongqing Municipality
简体中文
English
